Toward Automatic Variant Interpretation: Discordant Genetic Interpretation Across Variant Annotations for ClinVar Pathogenic Variants

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Purpose

High-throughput sequencing has revolutionized genetic disorder diagnosis, but variant pathogenicity interpretation is still challenging. Even though the Human Genome Variation Society (HGVS) provides recommendations for variant nomenclature, discrepancies in annotation remain a significant hurdle.

Methods

This study evaluated the annotation concordance between three tools— ANNOVAR, SnpEff, and Variant Effect Predictor (VEP)—using 164,549 two-star variants from ClinVar. The analysis used HGVS nomenclature string-match comparisons to assess annotation consistency from each tool, corresponding coding impacts, and associated ACMG criteria inferred from the annotations.

Results

The analysis revealed variable concordance rates, with 58.52% agreement for HGVSc, 84.04% for HGVSp, and 85.58% for the coding impact. SnpEff showed the highest match for HGVSc (0.988), while VEP bettered for HGVSp (0.977). The substantial discrepancies were noted in the Loss-of-Function (LoF) category. Incorrect PVS1 interpretations affected the final pathogenicity and downgraded PLP variants (ANNOVAR 55.9%, SnpEff 66.5%, VEP 67.3%), risking false negatives of clinically relevant variants in reports.

Conclusions

These findings highlight the critical challenges in accurately interpreting variant pathogenicity due to discrepancies in annotations. To enhance the reliability of genetic variant interpretation in clinical practice, standardizing transcript sets and systematically cross-validating results across multiple annotation tools is essential.

Graphic abstract

This study examined the consistency of variant annotations produced by three widely used open-source tools—ANNOVAR, SnpEff, and VEP—against 164,549 ClinVar two starts variants. The investigation covers HGVS-based transcript, protein nomenclature and coding impact annotation. The results showed that none of the tools were fully consistent with ClinVar across all coding impact categories, particularly in the LoF category, which exhibited the poorest consistency. This inconsistency may lead to discrepancies in PVS1 interpretation, affecting the final pathogenicity assessment. PVS1 loss resulted in a significant downgrading of PLP variants, potentially leading to the omission of clinically relevant variants in reports.

Article activity feed